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Summary 
A small animal model that could be infected with human immunodeficiency virus 1 (HIV-1) 
after peripheral inoculation would greatly facilitate the study of the pathophysiology of acute 
HIV-1 infection. The utility of SCID mice implanted with human fetal thymus and liver (SCID- 
hu mice) for studying peripheral HIV-1 infizction in vivo has been hampered by the requirement 
for direct intraimplant injection of H1V-1 and the continued restriction of the resultant  HIV-1 
infection to the human thymus and liver (hu-thy/liv) implant. This may have been due to the 
very low numbers  of human T  cells present  in  the  SCID-hu mouse peripheral  lymphoid 
compartment. Since the degree of the peripheral reconstitution of SCID-hu mice with human 
T cells may be a function of the hu-thy/liv implant size, we increased the quantity of hu-thy/liv 
tissue implanted under the renal capsule and implanted bu-thy/liv tissue under the capsules of 
both kidneys. This resulted in SCID-hu mice in which significant numbers of human T cells 
were detected in the peripheral blood, spleens, and lymph nodes. After intraimplant injection 
of HIV-1 into these modified SCID-hu mice, significant  HIV-1 infection was detected by quantitative 
coculture not only in the hu-tby/liv implant, but also in the spleen and peripheral blood. This 
indicated that HIV-1 infection can spread from the thymus to the peripheral lymphoid compartment. 
More importantly,  a similar degree of infection of the hu-thy/liv implant and peripheral lymphoid 
compartment occurred after peripheral  intraperitoneal  inoculation with HIV-1.  Active viral 
replication was indicated by the detection of HIV-1 gag DNA, HIV-1 gag RNA, and spliced 
tat/rev KNA in the hu-thy/liv implants,  peripheral blood mononudear cells (PBMC), spleens, 
and lymph nodes of these HIV-l-infected SCID-hu mice. As a first step in using our modified 
SCID-hu mouse model to investigate the pathophysiological  consequences of HIV-1 infection, 
the effect of HIV-1 infection on the expression of human cytokines shown to enhance HIV-1 
replication  was examined.  Significantly more of the HIV-l-infected SCID-hu mice expressed 
mKNA for human tumor necrosis factors c~ and/5, and interleukin 2 in their spleens, lymph 
nodes, and PBMC than did uninfected SCID-hu mice. This suggested that HIV-1 infection in 
vivo can stimulate the expression of cytokine mP,  NA by human T cells. Our modified SCID-hu 
mice may provide an improved model for studying the pathophysiology of HIV-1 infection in 
vivo and for investigating the effects of anti-HIV interventions on the prevention of disseminated 
HIV-1 infection. 
s 
exposure of an individual to an inoculum of HIV-1, 
an infectious cycle is initiated that leads to systemic dis- 
semination of HIV-1 and HIV-l-infected cells into lymphoid 
organs (1). The subsequent disease course may be determined 
by the sites to which HIV-1 is seeded during the acute stage 
of infection (1,  2).  The generation of immune responses 
directed against HIV-1 may result in a prolonged period of 
clinical latency (2). However, a quiescent state of HIV-1 dis- 
ease in the peripheral blood is often accompanied by ongoing 
active and progressive HIV-1 infection in lymphoid organs 
(3-5). Thus, examination  of the peripheral blood of HIV- 
1-infected individuals does not detect the high degree of covert 
HIV-1 replication taking place in lymphoid tissues (6). In- 
vestigation of the pathophysiology of acute HIV-1 infection 
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lymphoid organs during this stage.  SCID mice implanted 
with human fetal thymus and liver (SCID-hu mice)  1 are an 
attractive small animal model for studying in vivo HIV-1 
infection (7). However, so far, HIV-1 infection of the human 
fetal thymus and liver (hu-thy/liv) implanted in these mice 
has  only been reported to occur after direct intraimplant 
injection of HIV-1 and the resultant HIV-1 infection was 
restricted to the hu-thy/liv implant (8).  In this report we 
describe a modified SCID-hu mouse model in which dissem- 
inated HIV-1 infection occurs in the peripheral mouse lym- 
phoid organs and the hu-thy/liv implant after peripheral in- 
oculation with HIV-1. 
Materials and Methods 
Implantation of Huraan Tt~mic and Liver Tissue Into SCID Mice. 
Human fetal thymic and liver tissue were obtained from 17-21 gesta- 
tional week fetuses after the elective termination of pregnancy and 
implanted into SCID mice (6-8-wk-old) within 8 h of avaihbility 
as described (9). Briefly,  the fetal thymus was cut into pieces ('~0.3 
era  ~) along the grossly visible lines of thymic lobules and the fetal 
liver was cut into pieces ('~0.5 cm  3) and kept in ice-cold PBS until 
implantation. While kept on ice, the human fetal thymus and liver 
pieces described above were cut into 1-mm  3 pieces and then ap- 
proximately 10 pieces of each were loaded into a 16-gange needle 
with a rounded tip. The SCID mice were anesthetized with Pen- 
tobarbital (40-80 mg/kg), the left and right kidneys were sequen- 
tially exteriorized, a 0.5-mm incision was made in each kidney cap- 
suh,  and the 10 pieces of thymus and liver tissue obtained from 
the same donor were imphnted underneath the capsule using the 
16-gauge needle. After surgery, minimal morbidity and mortality 
was observed. 3 mo after implantation,  ;>95% of the grafts took 
and increased in size to >5  x  10  x  5 ram. The histological ap- 
pearance of the graft resembled that of normal human thymus and 
the expected thymocyte subpopulations were observed by flow 
cytometry as  described (9). All  tissue used came  from HIV-1 
seronegative donors. The consent forms and procedures used in 
this study were reviewed  and approved by the Albert Einstein Col- 
lege of Medicine Committee on Cliuical Investigation. 
Flow CytometricAnalysis.  Mononuclear  ceUs  were harvested  from 
the peripheral blood, spleens, and LN of the SCID-hu mice and 
stained with PE-, FITC, or peridinin chlorophyll  protein-conjugated 
mouse mAb to human CD4 (Leu 3a, Becton Dickinson, Moun- 
tain View, CA), human CD8 (l.eu 2a, Becton Dickinson), human 
CD3 (I.eu 4, Becton Dickinson), or human CD45 as described (9). 
TCK V gene expression was analyzed by staining mononuclear 
cells with PerCP-conjugated mouse mAb to human CD4 (Leu 3a), 
PE-conjugated  mouse mAb to human CD8 (l.eu 2a), and FFIC-con- 
jugated mouse mAb to either TCR Vfl2, VflSa, Vfl5b, V85c, Vfl6, 
Vfl8, Vf112,  Vf119, or Vot2 (T Ceil Diagnostics, Cambridge, MA). 
Expression of  human CD45, CD3, CD4, or CD8 or human CD4, 
CDS, and TCR V genes by lymphocytes present in the SCID-hu 
mice were then assessed  by three-color  flow cytometric analysis using 
a FACSc.an  |  cell analyzer with LYSIS-II software (Becton Dick- 
inson). Nonviable cells and unlysed RBC were gated out based 
on their forward and side scatter profiles, and lymphocyte gates 
1 Abbreviations used in this paper: flz-MG, flz-microglobulin;  hu-thy/liv, 
human fetal  thymus  and fiver;  SCID-hu,  SCID  mice  implanted  with human 
fetal thymus and fiver. 
were set on the basis of forward and side scatter profiles to cor- 
respond to gates set to control human (from healthy adult volun- 
teer) lymphocytes. Cut-off values for the quadrants were set after 
compensation for PE vs. FITC vs. PerCP emission based on the 
analysis of single, double, and triple staining of positive and nega- 
five control samples (human adult and C.B-17 mouse mononudear 
cells) and of the appropriate mouse IgG isotype controls. 
Infection of SCID-hu  Mice with HII/=L  The patient isolate of 
HIV-1 used in this study, HIV-I~, was obtained after coculture 
of  PBMC isolated from a 2-yr-old HIV-l-infected child with PHA- 
activated donor PBMC as described (10). The initial coculture su- 
pernatant was harvested  and cocultured with PHA-activated  PBMC 
to expand the quantity of HIV-I~. The secondary coculture su- 
pematant was harvested and aliquots were frozen in liquid nitrogen. 
The tissue culture infective  doses0 (TCIDs0) of the supernatant was 
determined by culturing titered dilutions of a thawed aliquot with 
PHA-activated donor PBMC (106) in a total vohme of 2.0 ml of 
RPMI 1640 with FCS (10% vol/vol) and Ib2 (32 U/ml). After 
2 wk of culture, the p24 antigen content of the culture supema- 
tam was measured by using the HIV-1 p24 core profile ELISA assay 
(Dupont-NEN, Wilmington, DE). The lowest dilution of super- 
natant that infected at least half of the quadruplicate cultures with 
HIV-1 was taken as the end point or TCIDs0. SCID-hu mice were 
infected either by direct injection of 300 TCIDs0 of HIV-lzs in a 
volume of 30 #1 into one hu-thy/liv implant or by intraperitoneal 
injection  of 8,000 or 800 TCIDs0 of HIV-12s in  a volume of 
8OO #1. 
HIV Viral Culture.  The titer of HIV-l-infected  mononuclear 
cells present in the peripheral blood, spleens, thymic implants, and 
LN of the SCID-hu mice, was determined as described (11, 12). 
Fivefold dilutions of PBMC ranging from 10  ~ cells to 3.2  x  10  ~ 
were cultured at 37~  in quadruplicate cultures in 24-weR culture 
plates with PHA-activated donor mononudear cells (106) in a total 
vohime of 2.0 ml of RPMI 1640 with added FCS (10% vol/vol) 
and IL-2 (32 U/ml). After 1-2 wk of  culture, the p24 antigen con- 
tent of the culture supematant was measured as described above. 
The lowest number of added PBMC that infected at least half of 
the quadruplicate cultures with HIV-1 was taken as the end point 
or TCID and the data are presented as TCID/10  ~ PBMC (11). 
HIVl-specific  DNA and RNA PCR.  The presence of HIV-1 
DNA and RNA gag-encoded sequences and spliced tat/rev mRNA 
sequences were assessed by PCK as described (13, 14). Briefly, 
mononuclear ceils from the SCID-hu mice were lysed in gnanidine 
isothiocyanate (4 M) buffer, cellular DNA and RNA were sepa- 
rated by cesium chloride (5.7 M) density gradient centrifugation 
and precipitated with ethanol. For DNA PCR, the HIV-1 DNA 
(1 #g) was amplified for 35 cycles with a primer pair specific for 
the gag gene segment (SK38/39), electrophoresed through 1.5% 
NuSieve/0.5% SeaKem agarose (FMC Corp. BioProducts, Rock- 
land, ME) gel containing  ethidiura  bromide, and the amplified 
product was detected under ultraviolet light. HIV-1 RNA was de- 
tected by PCR amplification  of reverse  transcribed RNA (RT-PCR) 
as described (13). Briefly,  after treatment of the cellular RNA with 
RNase-free  DNase  (Boehringer  Mannbeim,  Indianapolis, IN), 
RNA (7 #g) in 7 #1 of ddHaO was mixed with 4 #1 of 5 x  buffer 
(250 mM Tris-HCl, pH 8.3/375 raM KC1/15 mM MgCh), 2 #1 
dithiothreitol (100 raM), 1 #1 of  random heaamers (GIBCO BRL, 
Gaithersburg, MD) and 5 #1 mixed dNTPs (2 raM each). Samples 
were mixed, heated to 65~  for 10 min, cooled on ice for 5 min 
and then 1 #1 (200 U) of  Superscript reverse  transcriptase (GIBCO 
BRL) was added. This final reaction mixture was vortexed, briefly 
spun down,  incubated at 37~  for 60 rain,  and then placed on 
ice. HIV-1 eDNA was amplified either with SK38/39 or a primer 
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Specifidty of the amplified product was confirmed by hybridiza- 
tion of a Southern blot of the amplified DNA and cDNA with 
a  3"-[32p]ATP--labeled internal  probe specific for  the  SK38/39 
product (SK19) or the TR-5/TR-3 product (TR-4). A given sample 
was regarded as positive ff PCIL amplification resulted in a DNA 
product of the predicted size that hybridized to the specific  internal 
probe. Positive  and negative controls were included in all runs and, 
to prevent contamination, suggested guidelines for PCR quality 
control were followed (15). For RT-PCR, the absence of residual 
DNA template was verified  by the absence of an amplified  product 
after PCR amplification of DNase-treated samples that had not 
been reverse transcribed. 
Detection of Human Cytokine Gene Expression b,/ RT-PCR.  The 
pattern of in vivo human cytokine expression of the human cells 
present in SCID-hu mice was assessed by using a modification of 
a previously described technique (16). To ensure that the PCR 
amplification  product was of  human origin, we designed  the primers 
so that the nucleotide sequence of the 3' end was complementary 
to a human cytokine cDNA sequence that was not present on the 
mouse cytokine cDNA. Derivation of the PCR product  from 
mRNA was insured by designing primer pairs that yidded an 
amplification product that spanned exon-exon  junctions. After re- 
verse transcription of total RNA (7/~g) extracted from the hu- 
thy/liv implant, PBMC, spleen, and LN of the SCID-hu mice, 
cDNA was amplified  by PCR with human cytokine-specific  primers 
for 60 cycles  of denaturation at 94~  for 1 rain, annealing at 65~ 
for I rain, and extension at 72~  for 1 rain. The presence of the 
target mRNA was indicated by the presence of an amplification 
product of the predicted size after fractionation of the PCR prod- 
ucts by electrophoresis and ethidium bromide staining. The primer 
pairs for each  cytokine  were selected  from published  DNA sequences 
based on previously described guidelines (17). The nuclcotide se- 
quences for 5' and 3' primers respectively  were:/~z-microglobulin 
(/~2-MG), TC~CTTGAGGCTATCCAGCGT and GTGGTT- 
CACACGGCAGC~ATACTC;  IL-2, CATTGCACTAAGTCT- 
TCK2AC'I'IGCACTIGTCACA  and ~GTCCCT- 
GC~TCTT;  IL-4, CTCACAGAGCAGAAGACTCTG'ICK2  and 
AAGCCCGCCAGC~CCCAGAGGTICC3~ IL-6, TAC~CCTC- 
GACGGCATCTCAGCCC  and  CTGGTTCTGTC~C33GCAG- 
CTTCGTCAGC; TNF-~, CGCTCCCCAAGAAGACAGGGG- 
GCC and GATGGCAGAGAGGAGGTTGACCTIGGT;  TNF-~, 
CCCA~CC'TC~TGTTG  and G'IGC~TGGATAGC"I~ 
GTCTCCCTC,  C,G. The amplification  product for each primer pair 
was confirmed  by demonstrating hybridization of  an internal probe 
to the predicted PCR amplification product after Southern blot- 
ting. Human specificity  for each primer pair was verified  by demon- 
strating that amplification of the predicted product did not occur 
after RT-PCR of RNA extracted from mouse mitogen-activated 
mononuclear ceUs. ALl samples were analyzed by RT-PCR for the 
presence of mouse or human/~2-microglobulin to verify the in- 
tegrity of the sample mRNA and the e~ciency of subsequent re- 
verse transcription. Positive and negative controls were included 
in all runs and suggested guidelines for PCR quality control were 
foUowed as described above. 
Results 
tYripheral Reconstitution of SCID-hu Mice with Human  T 
Cell.~  We had previously observed a correlation between the 
number of human T cells present in the peripheral blood of 
SCID-hu mice and the degree of growth of the implanted 
hu-thy/liv. Therefore, in order tO increase  the number of 
human T  cells present in the periphery of SCID-hu mice, 
we increased the quantity of hu-thy/liv tissue implanted under 
the renal capsule and implanted hu-thy/liv tissue under the 
capsules of  both kidneys. 3 mo after implantation, the number 
of human T  cells present in the peripheral lymphoid com- 
partment of SCID-hu mice constructed in this fashion was 
evaluated by three-color flow cytometric analysis of lympho- 
cytes in the peripheral blood, LN, and spleens for the expres- 
sion of human CD45, CD3, CD4, and CD8 and representa- 
tive two-dimensional dot histograms are shown in Fig.  1. 
Examination of human CD4 and CD8 expression  by lym- 
phocytes positive for human CD45 in SCID-hu mice con- 
structed in this fashion revealed that in the peripheral blood 
(n  =  25),  4.06  _+  0.49% were CD4 + and 1.34  _  0.20% 
were CD8 +,  in the spleen  (n  =  7),  4.91  +  2.04%  were 
CD4 +,  and 2.93  +_  1.21%  were CD8 +,  and in the LN 
(n  =  7),  8.64  +  3.93%  were CD4 + and 3.47  _+  1.38% 
were CD8 +.  To determine whether human T  cells  were 
present in the peritoneal cavity of these SCID-hu mice, peri- 
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Figure 1.  Detection  of human T cells in the periphery of SCID-hu 
mice. Lymphocytes  isolated from the peripheral blood (,4 and B), spleen 
(C and D), and LN (E and F) of SCID-hu mice were analyzed  by three- 
color flow  cytometry  for the e=pression of human CD45 and CD3 (.4, 
C, and E) and CD4 and CD8 (B, D, and F), as described in Materials 
and Methods. The percentages of cells in each quadrant are indicated. 
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cold PBS, assessed for the expression of human CD45, CD4, 
and  CD8,  and representative  two-dimensional dot  histo- 
grams are shown in Fig.  2.  As determined by three-color 
flow cytometric analysis of peritoneal exudate cells, 4.13  + 
3.84%  of the peritoneal exudate cells in  SCID-hu mice 
(n  =  3) were human CD45+CD4 + lymphocytes and 1.24 
_+  1.08%  were human CD45+CD8 + lymphocytes. The 
diversity of the human T  cells present in the periphery of 
SCID-hu mice was assessed by examining their expression 
of TCR Vfl genes after staining with a panel of TCR Vfl- 
specific mAb that recognize about 30%  of the peripheral 
human T cell population. As shown in Figure 3, a diverse 
population of human TCR Vfl subsets were observed in the 
periphery of SCID-hu mice. Thus, construction of SCID-hu 
mice in this fashion results in the significant reconstitution 
of the peripheral lymphoid compartment with a broad spec- 
trum of human T  cells. 
Infection of the Peripheral  Lymphoid Compartment of  SCID-hu 
Mice with HIV-1.  After direct inoculation of the hu-thy/liv 
implant with HIV-1, the SCID-hu mice were assessed for 
disseminated HIV-1 infection. Since hu-thy/liv was implanted 
in each kidney capsule of these SCID-hu mice, we could assess 
whether HIV-1 directly injected into the hu-thy/liv implanted 
in one kidney capsule could be systemically disseminated and 
infect the other hu-thy/liv implanted in the opposite kidney 
capsule. HIV-1 could be isolated by coculture of thymocytes 
from both the hu-thy/liv implants, and the splenocytes of 
SCID-hu mice 1 mo after direct unilateral HIV-1 inocula- 
tion into hu-thy/liv implants. The degree of HIV-1 infec- 
tion present in the HIV-l-injected hu-thy/liv implant, the 
uninjected hu-thy/liv implant in the opposite kidney,  the 
spleen, and PBMC was determined by quantitative coculture 
(Table 1). HIV-1 was isolated from as few as 320 thymocytes 
in all the injected hu-thy/liv implants, indicating the pres- 
ence of over 3,125 TCID/106 cells. A variable range of dis- 
seminated HIV-1  infection was observed with over 3,125 
TCID/106 cells in two of three uninjected hu-thy/liv im- 
plants and from 2 to 333 TCID/IO  6 cells in the spleens of 
five SCID-hu mice. In addition, HIV-1 was cocultured from 
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Figure 2.  Detection of human T ceils in the peritoneal cavity of SCID-hu 
mice. Mononuclear cells isolated by peritoneal lavage from the peritoneal 
cavities of SCID-hu mice were analyzed by three-color flow cytometry 
for the expression of (A) human CD45 and CD4 and (/3) CD45 and CDS, 
as described in Materials and Methods. The percentages of cells in each 
quadrant are indicated. 
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Figure 3.  Analysis of TCR Vfl subsets in the periphery of SCID-hu 
mice. Pooled lympho~tes isolated from the peripheral blood, spleen, and 
LN of SelD-hu mice were analyzed by three-color flow cytometry for 
the expression of human CD4, CD8, and the indicated TCK Vfl gene. 
The mean percentage (+STE) of human T cells in SCID-hu mice (n  = 
3) expressing CD4 or CD8 and VflSa, Vfl5b, Vfl5c, Vfl6, Vfl8, Vf112, 
or Vow2, and the percentage of human  T  cells in a  SCID-hu mouse 
(n  =  1) expressing  CD4 or CD8 and Vfl2 or Vf119, are indicated. 
PBMC obtained from the peripheral blood of three of these 
intraimplant-injected SCID-hu mice. Thus, T cells that be- 
come infected with HIV-1 in the hu-thy/liv implant can in- 
duce disseminated HIV-1 infection of SCID-hu mice that 
were constructed as described above. 
To examine the capacity of HIV-1 to infect SCID-hu mice 
by other routes, HIV-1 was inoculated into the peritoneal 
cavity of SCID-hu mice. I mo after HIV-1 inoculation, HIV-1 
was isolated by coculture from the hu-thy/liv implants of 
five of five SCID-hu mice injected with 8,000 TCIDs0, one 
of two SCID-hu mice injected with 800 TCIDs0,  and zero 
of two SCID-hu mice injected with 80 TCIDs0.  We con- 
firmed that the HIV-1 isolated was not residual virus from 
the initial inoculation by demonstrating that no HIV-1 was 
isolated by coculture from the spleens of unimplanted SCID 
mice 1 mo after injection with 8,000 TCIDs0 of HIV-12s. 
Assessment of the extent of HIV-1 infection by quantitative 
coculture indicated that the HIV-1 infection in the hu-thy/liv 
implant ranged from 625 to >3,125 TCID/106 cells (Table 
2), comparable to that which occurred after intraimplant in- 
fection of SCID-hu mice. HIV-1 infection ranging from >0.7 
to 25 TCID/106 cells was also detected in four of five spleens 
from the inoculated SCID-hu mice. In addition, the periph- 
eral blood of two SCID-hu mice assessed contained >2 and 
>5 TCID/106 cells. Thus, after peripheral inoculation with 
HIV-1, HIV-l-infected cells or HIV-1 can migrate from the 
periphery into the hu-thy/liv implant and infect human T 
cells present in the implant. 
Detection of HIV-1  DNA  and RNA  in  HIV-l-infected 
SCID-hu Mice.  The presence of HIV-1 DNA and RNA in 
the hu-thy/liv implants, and the peripheral lymphoid com- 
partment of the SCID-hu mice infected by inoculation of 
HIV-1 either into the hu-thy/liv implant or peritoneal cavity 
were assessed by PCR.  HIV-1 gag DNA was detected by 
SK38/39-primed PCR amplification in the hu-thy/liv im- 
516  Peripheral  HIV-1 Infection in SCID-hu Mice Table  1.  Infection of $CID-hu  Mice after Inoculation of the Hu-thy/liv  Implant  with HIV-1 
HIV-1  titer  (TCID/106 cells) 
Mouse  Injected implant  Uninjected  implant  Spleen  Blood 
T1  >3,125  ND"  5  ND 
T2  >3,125  ND  >2  ND 
T3  >3,125  >3,125  333  >2 
T4  >3,125  0  2  >1 
T5  >3,125  >3,125  >2  >1 
3 mo after implantation under the renal capsule of SCID mice, a hu-thy/liv implant in five SCID-hu mice was injected with 300 TCIDs0 of HlV-lzs. 
1 mo later, the mice were killed, mononuclear cells were isolated from the injected hu-thy/liv, the uninjected hu-thy/liv implanted in the opposite 
kidney, the spleen, and the peripheral blood,  extensively washed and, if suffldent ceils were available, quantitative coculture of mononuclear cells 
with PHA-activated PBMC (104) was performed.  After 7 d of culture,  an aliquot of the supernatant was harvested and assessed for the presence 
of p24 antigen. The coculture was considered positive if >100 pg/ml of p24 antigen was detected in the supernatant.  The data are presented as 
TCID/104 mononuclear cells and ")" indicates that the coculture was positive for the lowest number of cells added. 
* Not done. 
plant, PBMC, spleen, and LN of SCID-hu mice infected with 
HIV-1 either by intraimplant  injection  (Fig.  4 A) or by in- 
traperitoneal inoculation  (Fig. 4 B). In addition,  HIV-1 gag 
RNA was detected by SK38/39-primed RT-PCR in the hu- 
thy/liv  implant,  PBMC,  spleen,  and LN of SCID-hu mice 
infected with  HIV-1 either by intraimplant  injection  (Fig. 
4  C) or by intraperitoneal  inoculation  (Fig.  4 D).  To deter- 
mine whether ongoing viral replication was occurring in the 
HIV-l-infected SCID-hu mice, the expression oftat/rev spliced 
Table  2.  HIV-1  Infection of SCID-hu  Mice after Intraperitoneal 
Inoculation with HIV-I 
HIV-1 titer  (TCID/106 cells) 
SCID-hu mouse  Implant  Spleen  Blood 
P1  >3,125  0  ND* 
P2  >3,125  25  >5 
P3  >3,125  >0.7  ND 
P4  625  ;>0.7  ND 
P5  >3,125  >2  >2 
1 mo after intraperitoneal inoculation of SCID-hu mice with 8.0  x  104 
TCIDs0 (PI, P2, P4, and P5) or 8.0  x  103 TCIDs0 (P3) of HIV-12s, 
the mice were killed, mononudear ceils were isolated from the hu-thy/liv 
implant,  the spleen, and the peripheral blood, extensively washed and, 
ff suf~dent ceils were available, quantitative coculture of the mononuclear 
cells with PHA-activated PBMC (104) was performed. After 7 d of cul- 
ture,  an aliquot of the supernatant was harvested and assessed for the 
presence of p24 antigen. The coculture was considered positive if )100 
pg/ml of  p24 antigen was detected  in the supernatant. The data are present- 
ed as TCID/106 mononuclear ceils and ")" indicates that the coculture 
was positive for the lowest number  of added cells. 
* Not done. 
mRNA  was examined.  The presence of tat/rev mR.NA was 
detected  by  RT-PCR  in  the  hu-thy/liv  implant,  PBMC, 
spleen, and LN of SCID-hu mice infected with HIV-1 either 
by intraimplant injection (Fig. 4 E) or by intraperitoneal in- 
oculation  (Fig.  4 F).  Fig.  5  shows the results of assessment 
for the presence of gag DNA, gag RNA,  and tat/rev RNA 
in five SCID-hu mice infected by inoculation of HIV-1 into 
the hu-thy/liv implant (Fig. 5 A) and six SCID-hu mice in- 
fected by injection of HIV-1 into the peritoneal cavity (Fig. 
5 B).  No HIV-1 DNA  or cDNA was detected in SCID-hu 
mice that had not been infected with HIV-1 (data not shown). 
We confirmed that the HIV-1 DNA and cDNA detected was 
not  from the initial  inoculation  by demonstrating  that  no 
Figure  4.  Detection ofgas DNA and 
RNA and tat/rev RNA in the periphery 
of HIV-1-infccted SCID-hu  mice. The 
presence of gag DNA (A  and B), gag 
RNA (C and D), or tat/rev RNA (E and 
F) in  the hu-thy/liv  implants, PBMC, 
spleens, or LN of SCID-hu mice infected 
with HIV-1  by intraimphnt injection (A, 
C, and E) or intraperitoneal injection (B, 
D, and/:) was detected  by Southern blot- 
ting of PCR. amplified DNA or cDNA 
as described in Materials and Methods. 
The blots shown are reprt~entative  of data 
presented in Fig. 5 
517  Kollmann et al. Figure  5.  gag DNA and RNA and taz/rev P,  NA are detected  in the 
periphery  of  HIV-l-infected  SCID-hu  mice. (,4) After  intraimplant  injec- 
tion with HIV-lzs, five  SCID-hu mice  were assessed  for the presence of 
gag DNA in the PBMC (n -  4), LN (n -  4), spleens  (n -  4), and hu- 
thy/liv imphnts (n  -  5); ga,r RNA in the PBMC (n  -  4), LN (n  - 
4), spleens (n -  4), and hu-thy/liv  implants (n ~- 5); and taz/rev RNA 
in the PBMC (n -  3), LN (n -  3), spleens  (n -  4), hu-thy/liv  implants 
(n -  5) by Southern  blotting  of  PCK amplified  DNA or eDNA. (B) After 
intraperitoneal injection  with HIV-I~, six SCID-hu mice were assessed 
for the presence  of  gag DNA in the PBMC (n -  4), LN (n -  4), spleens 
(n  -  4), and hu-thy/liv implants (n  -  5); ga& RNA in the PBMC 
(a  -  2), LN (n  -  4), spleens (n -  6), and hu-thy/liv  implants (n  - 
6); and tat/~,~,  RNA in the PBMC (n -  3), LN (n -  4), spleens (n - 
5), hu-thy/liv  implants (n -  5) by Southern blotting of PCK amplified 
DNA or eDNA. The data are pru~-~ented  as the percent SCID-hu mice 
wherein the expression  of  the indicated  target  DNA or RNA was detected. 
HIV-1 DNA and eDNA was detected in the spleens of unim- 
planted SCID mice 1 mo after injection with 8,000 TCIDs0 
of HIV-lzs  (data not shown).  Thus,  productive infraction 
with HIV-1 and active viral replication was occurring in the 
periphery of SCID-hu mice infected by inoculation of HIV- 1 
either into the hu-thy/liv implant or into the peritoneal cavity. 
Since human CD4 + T cells were present in the peritoneal 
cavity of these SCID-hu mice, we examined whether they 
became infected with HIV-1 after intraperitoneal injection. 
After intraperitoneal injection of HIV-lzs (8,000  TCIDs0), 
peritoneal exudate cells were harvested, extensively washed, 
and their DNA was extracted. As shown in Fig. 5, HIV-1 
DNA was detected by SK38/39-primed PCR amplification 
in the peritoneal exudate cells of SCID-hu mice either I wk 
(lane I) or 4 wk (lane 2) after intraperitoneal injection. No 
HIV-1 DNA was detected in peritoneal exudate cells har- 
vested from unimplanted SCID mice  1 or 4  wk after in- 
traperitoneal injection with 8,000 TCIDs0 of HIV-12s (data 
not shown). 
Expression  of Human  Cytokine  Genes  in  HIV-l-infected 
SCID-hu Mice.  Since cytokines such as TNF-ol,  TNF-~, 
IL-2, IL-4, and IL-6 can modulate HIV-1 replication in vitro 
(2), human cytokine mlkNA expression in the hu-thy/liv im- 
plant, spleen,  LN, and PBMC of SCID-hu mice was ana- 
lyzed by RT-PCR with human mRNA-specific cytokine 
primers. The detection of human B2-MG mRNA indicated 
that human cells were present throughout the peripheral lym- 
phoid compartment of HIV-1-infected SCID-hu mice; how- 
ever, differences in human cytokine mRNA expression  by 
human cells present in different regions were observed (Fig. 
6). Analysis by IkT-PCR detected the expression of TNF-ol 
mRNA in the hu-thy/liv implant and spleen; TNF-B mRNA 
in the hu-thy/liv implant, spleen, and PBMC; IL-2 mRNA 
in  the hu-thy/liv implant and spleen;  and IL-4 and IL-6 
mRNA in the hu-thy/liv  implant. To assess the effect of  HIV-1 
infection on cytokine expression in SCID-hu mice, we com- 
pared the expression  of human mRNA encoding TNF-o~, 
TNF-B,  IL-2,  IL-4,  and  IL-6 in  the  hu-thy/liv implant, 
PBMC, spleens and LN of eight SCID-hu mice and seven 
HIV-i-infected SCID-hu mice. In the seven HIV-l-infected 
mice, active HIV-1 infection was demonstrated by the detec- 
tion of tat/rev mRNA in seven out of seven of the hu-thy/liv 
implants, seven out of seven spleens, six out of seven PBMC, 
and six out of seven LN (Fig.  7).  Expression of TNF-ol, 
TNF-B, and IL-2 mRNA was increased in the PBMC (Fig. 
7 B), LN (Fig.  7 C), and spleens (Fig.  7 D) of the HIV-1- 
infected SCID-hu mice. For eaample, whereas TNF-ot, TNF-B 
and IL-2 mRNA was detected in the spleens of one of eight, 
five of eight, and one of eight SCID-hu mice, respectively, 
they were detected in the spleens of five of six,  six of six, 
and three of  six HIV-1-infected SCID-hu mice, respectively. 
Taken together, this data suggests that HIV-1 infection in 
vivo can stimulate cytokine production by human T  cells. 
Discussion 
Previous reports using SCID-hu mice demonstrated that 
HIV-1 infection occurred exclusively in the implanted human 
organs and HIV-1 infection of the hu-thy/liv implant was 
only observed after direct injection into the implant (8). We 
demonstrated in our modified mouse model that after in- 
traperitoneal or intraimplant injection of HIV-1 into SCID- 
Figure  6.  Detection  of  gag DNA in peritoneal  ~- 
udate  cells  of  intraperitoneally  injected  SCID-hu  mice. 
Peritoneal  ~mdate  cells  were  harvested  from  SCID-hu 
mice I wk (lane  1) or 4 wk (lane  2) after  intraperitoneal 
injection of 8 x  10  3 TCIDso of HIV-lzs into SCID- 
hu mice. The presence ofga& DNA was detected  by 
Southern  blotting  of  PCR amplified  DNA as described 
in Materials  and Methods  and the blot shown  reflects 
the results  obtained  from  studying  two SCID-hu  mice. 
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cytokine  genes  in SCID-hu mice. The 
e~pression  of  /~z-MG,  TNF-a, 
TNF-fl, ID2, II.-4, and II.-6 mKNA 
in the indicated tissue of a SCID-hu 
mouse infected  by intraperitoneal in- 
jection of HIV-1 was determined by 
RT-PCR  as described  in Materials  and 
Methods. The amplification  products 
of the predicted size were visualized 
in ethidium bromide stained gels by 
UV radiation. 
hu mice,  significant  HIV-1 infection  occurred not  only in 
the implant, but also in peripheral tissues. Furthermore,  the 
presence of HIV-1 gag DNA, HIV-1 gag RNA, and spliced 
tat/rev RNA in the hu-thy/liv implants, PBMC, spleens, and 
LN of HIV-l-infected SCID-hu mice indicated that dissem- 
inated,  active HIV-1 infection occurred in SCID-hu mice after 
transmission of HIV-1 by intraimplant  injection,  as well as 
by intraperitoneal  inoculation. 
In the SCID-hu  model reported by Krowka et al.  (18), 
peripheral HIV-1 infection after inoculation into the hu-thy/llv 
implant may have been precluded by the presence of a mean 
level of only 0.7% of human T cells in the peripheral blood 
and  very low levels  of human  cells  in  the  spleens  of the 
SCID-hu mice used. The original SCID-hu mice were con- 
structed by implanting one to two fragments of human fetal 
thymus and liver under the capsule of one kidney in SCID 
mice (19). To augment the number of human T cells present 
in the periphery of SCID-hu mice, we increased the quantity 
of hu-thy/liv  tissue implanted  under  the renal capsule and 
implanted hu-thy/liv tissue under the capsules of  both kidneys. 
In 25 SCID-hu mice constructed in this manner,  a mean of 
6.4% ofthdr PBL were human T cells (4.06 _+ 0.49% human 
CD4 + T  cells  and  1.34  +  0.20%  human  CD8 + T  cells). 
It is possible that other variables such as the viability of the 
implanted fetal tissue or the implantation technique used may 
have also contributed to the increased engraftment of the pe- 
ripheral  lymphoid compartment  that  we observed. 
After injection of the hu-thy/liv implant in the SC/D-hu 
mice constructed in this fashion with HIV-1, systemic infec- 
tion of the implants,  spleens,  LN, and PBMC with HIV-1 
was observed. This indicated that human T cells can become 
infected with HIV-1 while maturing in the thymus, exit the 
thymus,  migrate to the periphery,  and then possibly infect 
T cells present in the peripheral blood, spleen, and LN. The 
observation that the HIV-1 hu-thy/liv infection on one side 
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Figure 8.  Comparison  of human cytokine  ~pression in SCID-hu mice 
and HIV-l-infccted SCID-hu mice. The expression of tat~m,, B2-MG, 
TNF-a, TNF-~, IL-2, IL-4, and II.-6 mRNA in the (A) PBMC, (B) LN, 
(C) spleens, and (D) hu-thy/liv implants of SCID-hu mice (n  =  8) and 
HIV-l-infected SCID-hu mice (n  -  7) was determined by RT-PCR as 
described  in Materials and Methods. The data are presented  as the percent 
SCID-hu mice  wherein the expression  of the indicated  mRNA was detected. 
was spread to the hu-thy/liv implanted in the opposite kidney 
suggested that free HIV-1 or HIV-l-infected ceils from the 
periphery can recirculate and infect the hu-thy/liv  implant 
on the opposite side. This assumption was confirmed by our 
observation that the hu-thy/liv implant could also be infected 
after intraperitoneal  HIV-1  inoculation. 
To determine whether free HIV-1 virus could infect the 
hu-thy/liv  implant,  we  intravenously  injected  8  x  104 
TCIDs0  of HIV-lzs  into  these  SCID-hu  mice  (data  not 
shown). No HIV-1 infection occurred in these SCID-hu mice, 
suggesting that the major route of HIV-1 dissemination oc- 
curred via HIV-l-infected cells and not via blood-mediated 
transfer  of HIV-1  during  intrathymic  injection or via sec- 
ondary  viremia.  In  our  SCID-hu  mouse  model,  human 
CD4 +  T  cells  were  present  in  the  peritoneal  cavity  and 
draining LN, and HIV- 1 infection in these ceils was detected 
by DNA PCR. Thus, it is possible that the first stage after 
intraperitoneal HIV-1 inoculation involves local infection of 
these human CD4 + cells with HIV-1. Subsequently, these 
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and mediate HIV-1 infection of the spleens, LN, and hu- 
thy/liv implants. Although the majority of T cell circulation 
is usually unidirectional from the thymus to the periphery, 
activated T ceils can migrate from the periphery to the thymic 
medulla (20-22). Since HIV-1 preferentially infects activated 
T cells (23), an intriguing possibility is that T cells infected 
with HIV-1 in the periphery migrate back to the thymus 
and thereby induce extensive HIV-1 infection of the thymus. 
Taken together, these data suggest that the human fetal thymus 
may serve as a reservoir for HIV-1 infection and mediate sub- 
sequent seeding of the periphery with HIV-l-infected T ceils. 
The capacity of cytokines such as TNF-ot, TNF-/3, and 
IL-6 to stimulate HIV-1 replication in cultured monocytes 
and T cells has been demonstrated (2). In addition, IL-2 and 
IL-4 synergistically  promote HIV-1 replication in cultured 
thymocytes (24), and IL-6 secreted by thymic epithdial cells 
upregnlate HIV-1 replication in chronically infected ceils (25). 
To assess the function of peripheral human T cells in SCID-hu 
mice and the in vivo role of cytokines in HIV-1 replication, 
the production of human cytokine mKNA in the hu-thy/liv 
implant and periphery of SCID-hu mice was assessed by KT- 
PCK. The mKNA for TNF-cx, TNF-/3, IL-2, IL-4, and IL-6 
was detected in all of the hu-thy/liv implants and expression 
of the mKNA for TNF-c~, TNF-fl, IL-2, and IL-4 was de- 
tected in the spleens, LN, and PBMC of some SCID-hu mice. 
HIV-1 infection in the hu-thy/liv implant of mice infected 
with HIV-1 by intraimplant and by intraperitoneal injection 
was,  as shown by quantitative coculture, at least  100-fold 
greater than that detected in the peripheral routine lymphoid 
organs of infected SCID-hu mice. The augmented degree of 
HIV-1 replication in the thymic implant may be related to 
the increased cytokine expression observed in the implants. 
After HIV-1 infection, an increased expression of TNF-ot, 
TNF-/3, and IL-2 mKNA was observed in the peripheral lym- 
phoid compa~-tctlent  of HIV-l-infected mice_ Although HIV-1 
infection in vitro may be enhanced by the presence of these 
cytokines, in vivo HIV-1 replication may not require their 
presence. This was indicated by the observation that expres- 
sion of mKNA for TNF-ot, TNF-/3, IL-2, and IL-4 was not 
detected in three of six LN wherein the detection of tat/rev 
mKNA indicated that active HIV-1 replication was occur- 
ring. Since expression by human T cells of mKNA for TNF-c~ 
(26), TNF-/3 (27),  and IL-2 (28) are increased after activa- 
tion, the data in this report indicated that HIV-1 infection 
may induce in vivo T cell activation. This is compatible with 
the recent observation that in vitro HIV-1 infection activates 
TNF-c~ and TNF-/3 gene expression via the HIV-1 transac- 
tivating Tat protein (29). Therefore, the use of species-specific 
cytokine KT-PCK in these SCID-hu mice should provide 
a valuable modal for exploring the in vivo role of cytokines 
in HIV-1 infection. 
Recently it was shown that HIV directly injected into hu- 
thy/liv implants in SCID-hu mice induces depletion of thymo- 
cytes (30, 31). We did not observe this degree of suppression 
of thymopoiesis 1 mo after infection of the thymic implants 
of our SCID-hu mice with HIV-t2s. This discrepancy most 
likely is related to the variable pathogenesis of different HIV-1 
isolates as observed by Bonyhadi et al. (30).  Variability in 
the behavior of thymic infection with different HIV-1 strains 
could also account for the observation that only two of three 
HIV-l-infected thymuses obtained from human abortuses 
were histologically abnormal (32). 
Although the behavior of HIV-1 in SCID-hu mice may 
differ from that occurring in humans, it is intriguing to apply 
insights obtained with this mouse model to the controversy 
regarding whether vertical transmission of HIV-1 in humans 
occurs in utero, intrapartum, or postpartum. Although HIV-1 
was detected in fetal lymphoid organs (33, 34), it is identified 
in less than half of the peripheral blood of HIV-l-infected 
newborns (35-37). It is possible that after intrauterine trans- 
mission, HIV-1 localizes to lymphoid organs where its pres- 
ence escapes  detection. The high degree of lymphocyte  prolifer- 
ation occurring in the neonatal thymus makes it an attractive 
environment wherein substantial replication of HIV-1 can 
occur (1). Various T cell precursor populations in the thymus 
including the  immature "triple  negative"  CD3-  CD4  h~- 
CD8- T cell precursors and the more mature CD4 § CD8 + 
thymocytes are  susceptible  to HIV-1  infection (38).  Our 
SCID-hu mouse model data indicate that human feral thymus 
can become infected after peripheral exposure to HIV-L Fur- 
thermore, after becoming infected with HIV-1 in the thymic 
environment, T ceils can migrate from the thymus and mediate 
peripheral dissemination of the HIV-1 infection. Taken to- 
gether, these in vivo studies suggest that peripheral ceils in- 
fected with HIV-1 in utero may home to the thymus where 
they can infect thymocytes with HIV-1 and thereby mediate 
subsequent infection of peripheral lymphoid tissues. Exami- 
nation of peripheral blood immediately after birth may not 
detect the high degree of HIV-1 replication occurring in the 
thymus, spleen, or LN. This is comparable to the dichotomy 
between the very active HIV-1 infection observed in LN and 
the low degree of HIV-1 infection seen in peripheral blood 
during the latent phase of HIV-1 infection in adults (4). There- 
fore, our SCID-hu mice may provide an improved modal for 
studying the role of prenatal and postnatal anti-HIV inter- 
ventions on the prevention of vertical transmission of HIV-1. 
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